Skip to main content
Caplight Logo









Abcely

Abcely

Private
NantesHealthcare & Life Scienceshttps://www.abcely.com/

Last Round

Seed

Sep 22, 2023

Total Funding Raised

$2.6M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Abcely is a biotechnology company developing a proprietary platform for orally active sIgA-based immunotherapy to treat mucosal cancers and chronic mucosal diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

sIgAsecretory IgAmucosal immunotherapyoral biologicsbiotech drug discoveryorally active therapeuticsmucosal diseasebiologics R&Ddrug out-licensingpreclinical validationbiotech startuptherapeutic candidatemucosal cancernext-gen immunotherapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Abcely Comparables

Compare Abcely with similar companies based on industry and business-model similarity.

Abcely comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Mage Biologics Inc.
78%
Epsilogen
77%
Sorriso Therapeutics
72%

Abcely Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 22, 2023

Key People

Founding team and executive leadership

Olivier Favre-Bulle

Chief Technology Officer

Executive Team

Abcely Investors

Notable investors and investment history

Abcely investors
InvestorRounds
MATWINSeed
GO CapitalSeed
Angels SantéSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors grew 306% MoM, reaching 2.1K.

  • Sep 22, 2023

    $2.6M round from GO Capital and 3Biotech

Abcely Filings

Explore SEC and related filing metadata, where available.

Abcely filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Abcely's valuation, stock price, and market status.

Is Abcely a public or private company?

Abcely is a private company.

What is the current stock price of Abcely?

Abcely is a private company with no public stock price. No recent secondary market data is available.

How much is Abcely worth (valuation)?

Valuation information for Abcely is not publicly available.

Can I buy Abcely stock?

Abcely shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Abcely's last funding round?

Abcely's most recent funding round was Seed on September 22, 2023.

Who are the main investors in Abcely?

Key investors in Abcely include MATWIN, GO Capital, Angels Santé.

Will Abcely IPO soon?

No public IPO plans have been announced for Abcely.

How can I track Abcely secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Abcely's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNantes
Employee Range5
Year Founded2022
Last FundingSep 22, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?